2017-11-28
|
Extensive virologic and immunologic characterization in an HIV-infected individual following allogeneic stem cell transplant and analytic cessation of antiretroviral therapy: A case study
published
| article-journal
doi:10.1371/journal.pmed.1002461
|
2020-04-23
|
Augmented Curation of Unstructured Clinical Notes from a Massive EHR System Reveals Specific Phenotypic Signature of Impending COVID-19 Diagnosis
unknown status
| post
doi:10.1101/2020.04.19.20067660
|
2020-05-23
|
Longitudinal laboratory testing tied to PCR diagnostics in COVID-19 patients reveals temporal evolution of distinctive coagulopathy signatures
unknown status
| post
doi:10.1101/2020.05.21.20109439
|
2020-06-19
|
Multi-pronged human protein mimicry by SARS-CoV-2 reveals bifurcating potential for MHC detection and immune evasion
unknown status
| post
doi:10.1101/2020.06.19.161620
|
2020-07-03
|
Plasma IL-6 Levels following Corticosteroid Therapy as an Indicator of ICU Length of Stay in Critically ill COVID-19 Patients
unknown status
| post
doi:10.1101/2020.07.02.20144733
|
2020-07-28
|
Exploratory analysis of immunization records highlights decreased SARS-CoV-2 rates in individuals with recent non-COVID-19 vaccinations
unknown status
| post
doi:10.1101/2020.07.27.20161976
|
2020-10-02
|
Benchmarking evolutionary tinkering underlying human–viral molecular mimicry shows multiple host pulmonary–arterial peptides mimicked by SARS-CoV-2
published
| article-journal
| CC-BY
doi:10.1038/s41420-020-00321-y
|
2020-10-11
|
Enoxaparin is associated with lower rates of thrombosis, kidney injury, and mortality than Unfractionated Heparin in hospitalized COVID patients
unknown status
| post
doi:10.1101/2020.10.06.20208025
|
2020-10-30
|
Pre-existing conditions are associated with long-COVID patients hospitalization, despite confirmed clearance of SARS-CoV-2 virus
unknown status
| post
doi:10.1101/2020.10.28.20221655
|
2020-11-10
|
Healthcare disparities among anticoagulation therapies for severe COVID-19 patients in the multi-site VIRUS registry
unknown status
| post
doi:10.1101/2020.11.06.20226035
|
2020-12-04
|
Longitudinal lab test analysis confirms pre-existing anemia as a severe risk factor for post-viral clearance hospitalization in COVID-19 patients
unknown status
| post
doi:10.1101/2020.12.02.20242958
|
2020-12-04
|
Mapping each pre-existing conditions association to short-term and long-term COVID-19 complications
unknown status
| post
doi:10.1101/2020.12.02.20242925
|
2021-02-18
|
FDA-authorized COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system
unknown status
| post
doi:10.1101/2021.02.15.21251623
|
2021-03-15
|
Plasma IL-6 levels following corticosteroid therapy as an indicator of ICU length of stay in critically ill COVID-19 patients
published
| article-journal
| CC-BY
doi:10.1038/s41420-021-00429-9
|
2021-04-05
|
COVID-associated pediatric hospitalization and ICU admission trends across a multi-state health system and the broader US population
unknown status
| post
doi:10.1101/2021.04.02.21254593
|
2021-04-07
|
Female-male differences in COVID vaccine adverse events have precedence in seasonal flu shots: a potential link to sex-associated baseline gene expression patterns
unknown status
| post
doi:10.1101/2021.04.01.21254798
|
2021-05-31
|
Antigenic minimalism of SARS-CoV-2 is linked to surges in COVID-19 community transmission and vaccine breakthrough infections
unknown status
| post
doi:10.1101/2021.05.23.21257668
|
2021-06-02
|
The Female Predominant Persistent Immune Dysregulation of the Post COVID Syndrome: A Cohort Study
unknown status
| post
doi:10.1101/2021.05.25.21257820
|
2021-06-22
|
Antigenic minimalism of SARS-CoV-2 is linked to surges in COVID-19 community transmission and vaccine breakthrough infections
unknown status
| post
| CC-BY
doi:10.21203/rs.3.rs-555451/v1
|
2021-07-05
|
COVID-19 vaccines dampen genomic diversity of SARS-CoV-2: Unvaccinated patients exhibit more antigenic mutational variance
unknown status
| post
doi:10.1101/2021.07.01.21259833
|
2021
|
Vaccination Safety
published
| article-journal
doi:10.1016/j.mayocp.2021.05.004
|
2021-07-27
|
Mapping each pre-existing condition's association to short-term and long-term COVID-19 complications
published
| article-journal
| CC-BY
doi:10.1038/s41746-021-00484-7
|
2021-09-07
|
Durability analysis of the highly effective BNT162b2 vaccine against COVID-19
unknown status
| post
doi:10.1101/2021.09.04.21263115
|
2021-08-08
|
Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence
published
| post
doi:10.1101/2021.08.06.21261707
|
2021-08-19
|
Intravenous bamlanivimab use associates with reduced hospitalization in high-risk patients with mild to moderate COVID-19
published
| article-journal
doi:10.1172/jci151697
|
2021-04-23
|
Cerebral venous sinus thrombosis (CVST) is not significantly linked to COVID-19 vaccines or non-COVID vaccines in a large multi-state US health system
unknown status
| post
doi:10.1101/2021.04.20.21255806
|
2021-05-28
|
Prior Statins Use and Risk of Mortality and Severe Disease from COVID-19: A Systematic Review and Meta-Analysis
published
| article-journal
doi:10.1093/ofid/ofab284
|
2021-02-24
|
FDA-approved COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system
unknown status
| post
| CC-BY
doi:10.21203/rs.3.rs-237155/v1
|
2022-02-03
|
Calm before the Storm
published
| article-journal
doi:10.1056/nejmcps2111163
|
2020-12-02
|
Long-term SARS-CoV-2 RNA shedding and its temporal association to IgG seropositivity
published
| article-journal
| CC-BY
doi:10.1038/s41420-020-00375-y
|
2021-02-23
|
Real-time analysis of a mass vaccination effort via an Artificial Intelligence platform confirms the safety of FDA-authorized COVID-19 vaccines
unknown status
| post
doi:10.1101/2021.02.20.21252134
|
2021-06-16
|
Cerebral Venous Sinus Thrombosis is not Significantly Linked to COVID-19 Vaccines or Non-COVID Vaccines in a Large Multi-State Health System
published
| article-journal
| CC-BY
doi:10.1016/j.jstrokecerebrovasdis.2021.105923
|
2021-04-30
|
Real-world effectiveness of Ad26.COV2.S adenoviral vector vaccine for COVID-19
unknown status
| post
doi:10.1101/2021.04.27.21256193
|